|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/16 | |
| A61K 9/00 | |||
| A61P 25/00 |
| (11) | Number of the document | 3318267 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16818303.6 |
| Date of filing the European patent application | 2016-07-04 | |
| (97) | Date of publication of the European application | 2018-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2016/007203 |
| Date | 2016-07-04 |
| (87) | Number | WO 2017/003270 |
| Date | 2017-01-05 |
| (30) | Number | Date | Country code |
| 201562187867 P | 2015-07-02 | US | |
| 20150187297 | 2015-12-28 | KR |
| (72) |
LEE, Jin-Kyung, KR
BYUN, Han-Yeul, KR
JUNG, Myung-Eun, KR
LEE, Kyu-Hyun, KR
|
| (73) |
Medigenebio Corporation,
107 Ihyeon-ro 30beon-gil Giheung-gu Yongin-si, Gyeonggi-do 446-855,
KR
Green Cross Corporation, (Bojeong-dong) 107 Ihyeon-ro 30beon-gil Giheung-gu, Yongin-si, Gyeonggi-do 16924, KR |
| (54) | HUNTER SYNDROME THERAPEUTIC AGENT |
| HUNTER SYNDROME THERAPEUTIC AGENT |